<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04935892</url>
  </required_header>
  <id_info>
    <org_study_id>17044-H34</org_study_id>
    <nct_id>NCT04935892</nct_id>
  </id_info>
  <brief_title>Slippers to Reduce Transfer From Floors to Surfaces</brief_title>
  <official_title>Impact of Wearing Slippers on Transfer of Bacteriophage MS2 From Floors in Patient Rooms to Bedding and Surfaces</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Louis Stokes VA Medical Center</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Louis Stokes VA Medical Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this study is to determine if wearing slippers will reduce transfer of&#xD;
      bacteriophage MS2 from hospital room floors to surfaces in the room and hands of patients.&#xD;
      Subjects are randomized to wear slippers versus standard care and cultures are collected at&#xD;
      24 and 48 hours to assess transfer of bacteriophage MS2 from the floor to high-touch&#xD;
      surfaces, personal items, bedding, socks or feet, and hands of patients.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The goal of this study is to determine if wearing slippers will reduce transfer of&#xD;
      bacteriophage MS2 from hospital room floors to surfaces in the room and hands of patients.&#xD;
      Hospitalized patients are enrolled and randomized to wear slippers any time they are out of&#xD;
      bed versus standard care. Bacteriophage MS2 is inoculated onto a site on the floor between&#xD;
      the patient bed and the bathroom. Cultures are collected at 24 and 48 hours to assess&#xD;
      transfer of bacteriophage MS2 from the floor to high-touch surfaces (bed rail, bedside table,&#xD;
      telephone, call button), personal items, bedding, socks or feet, and hands of patients.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">August 1, 2020</start_date>
  <completion_date type="Actual">April 20, 2021</completion_date>
  <primary_completion_date type="Actual">April 20, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Randomized trial</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
    <masking_description>Lab personnel processing cultures blinded to the study group</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Contamination of a composite of high-touch surfaces, personal items, socks/feet, bedding, and hands</measure>
    <time_frame>48 hours</time_frame>
    <description>Cultures for MS2</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">34</enrollment>
  <condition>Transmission, Other/Miscellaneous</condition>
  <arm_group>
    <arm_group_label>Slippers</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Patients wear slippers any time they are out of bed with a goal of avoiding any contact between socks/feet and the floor</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients receive standard care with no intervention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Slippers</intervention_name>
    <description>Patients in the intervention group wear slippers when out of bed</description>
    <arm_group_label>Slippers</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult patients of 18 years of age or older&#xD;
&#xD;
          -  Ambulatory&#xD;
&#xD;
          -  Able to demonstrate an understanding of study procedures&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Unable or unwilling to fulfill study requirements.&#xD;
&#xD;
          -  Expected length of stay less than 48 hours&#xD;
&#xD;
          -  Any patient deemed not suitable for study participation at the discretion of the study&#xD;
             investigator&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Curtis J Donskey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Cleveland VA Medical Center</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Cleveland VA Medical Center</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44106</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>June 12, 2021</study_first_submitted>
  <study_first_submitted_qc>June 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">June 23, 2021</study_first_posted>
  <last_update_submitted>June 24, 2021</last_update_submitted>
  <last_update_submitted_qc>June 24, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Louis Stokes VA Medical Center</investigator_affiliation>
    <investigator_full_name>Dr. Curtis Donskey</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>Floor</keyword>
  <keyword>Bacteriophage MS2</keyword>
  <keyword>Contamination</keyword>
  <keyword>Environment</keyword>
  <keyword>Healthcare-associated pathogens</keyword>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>We will provide de-identified individual participant data to those who provide a request in writing.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Analytic Code</ipd_info_type>
    <ipd_time_frame>Available 6/22/21 through 6/22/24</ipd_time_frame>
    <ipd_access_criteria>Written request</ipd_access_criteria>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Statistical Analysis Plan</document_type>
      <document_has_protocol>No</document_has_protocol>
      <document_has_icf>No</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>April 20, 2021</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/92/NCT04935892/SAP_000.pdf</document_url>
    </provided_document>
  </provided_document_section>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

